Literature DB >> 8386705

Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis.

T Doi1, M Ando, T Akaike, M Suga, K Sato, H Maeda.   

Abstract

Susceptibility of three different strains of Mycobacterium avium complex (MAC), i.e., one strain of M. avium (Mino) and two strains of M. intracellulare (31F093T and KUMS 9007), to nitric oxide (NO) generated by rat alveolar macrophages (M phi) or NO generated chemically by acidification of NO2- was examined in vitro. We also investigated the effects of NO on phagocytosis and superoxide anion (O2-) generation by M phi. The intracellular growth of M. avium Mino was significantly suppressed by NO generated by gamma interferon (IFN-gamma)-stimulated M phi, whereas that of two strains of M. intracellulare (31F093T and KUMS 9007) was not. M. avium Mino was also more susceptible to NO generated chemically by acidification of NO2- than the two M. intracellulare strains. In L-arginine (1 mM)-containing medium, NO release from the M phi assessed by measuring NO2- increased as the concentration of IFN-gamma increased. The enhancing potential of IFN-gamma for NO release became more pronounced when M phi were infected with 31F093T, an NO-resistant strain. A large amount of NO generated by IFN-gamma-stimulated M phi suppressed both phagocytosis and O2- generation by the M phi, especially after infection of the M phi with strain 31F093T. These results indicate that the intracellular growth of MAC is not always inhibited by NO generated by immunologically activated M phi; rather, NO generation induced by infection with an NO-resistant MAC strain suppresses phagocytosis of the M phi, which may allow extracellular spreading of such NO-resistant mycobacteria. Therefore, the pathogenic potential of MAC may be partly attributed to its resistance to NO.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386705      PMCID: PMC280792          DOI: 10.1128/iai.61.5.1980-1989.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells.

Authors:  J C Drapier; J B Hibbs
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

2.  Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.

Authors:  D J Stuehr; M A Marletta
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

3.  Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.

Authors:  I Flesch; S H Kaufmann
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

4.  Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.

Authors:  D L Granger; J B Hibbs; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

5.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

6.  Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.

Authors:  L E Bermudez; L S Young
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

7.  Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction.

Authors:  T Akaike; M Yoshida; Y Miyamoto; K Sato; M Kohno; K Sasamoto; K Miyazaki; S Ueda; H Maeda
Journal:  Biochemistry       Date:  1993-01-26       Impact factor: 3.162

8.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells.

Authors:  J B Hibbs; Z Vavrin; R R Taintor
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

10.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.

Authors:  J B Hibbs; R R Taintor; Z Vavrin
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

View more
  37 in total

1.  The gills are an important site of iNOS expression in rainbow trout Oncorhynchus mykiss after challenge with the gram-positive pathogen Renibacterium salmoninarum.

Authors:  J J Campos-Perez; M Ward; P S Grabowski; A E Ellis; C J Secombes
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha).

Authors:  K Sato; T Akaki; H Tomioka
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice.

Authors:  K Umezawa; T Akaike; S Fujii; M Suga; K Setoguchi; A Ozawa; H Maeda
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Low concentrations of nitric oxide exert a hormetic effect on Mycobacterium tuberculosis in vitro.

Authors:  William Benjamin Brugmann; Marcia A Firmani
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads.

Authors:  S Ehlers; S Kutsch; J Benini; A Cooper; C Hahn; J Gerdes; I Orme; C Martin; E T Rietschel
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

6.  Protection of mice from Mycobacterium avium infection by recombinant interleukin-12.

Authors:  K Kobayashi; T Kasama; J Yamazaki; M Hosaka; T Katsura; T Mochizuki; K Soejima; R M Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro.

Authors:  L O'Brien; J Carmichael; D B Lowrie; P W Andrew
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection.

Authors:  B M Saunders; Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  The role of nitric oxide in mycobacterial infections.

Authors:  Chul-Su Yang; Jae-Min Yuk; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

10.  A new paradigm for antimicrobial host defense mediated by a nitrated cyclic nucleotide.

Authors:  Tatsuya Okamoto; Shahzada Khan; Kohta Oyama; Shigemoto Fujii; Tomohiro Sawa; Takaaki Akaike
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.